430 related articles for article (PubMed ID: 21828272)
1. An integrated approach to dissecting oncogene addiction implicates a Myb-coordinated self-renewal program as essential for leukemia maintenance.
Zuber J; Rappaport AR; Luo W; Wang E; Chen C; Vaseva AV; Shi J; Weissmueller S; Fellmann C; Taylor MJ; Weissenboeck M; Graeber TG; Kogan SC; Vakoc CR; Lowe SW
Genes Dev; 2011 Aug; 25(15):1628-40. PubMed ID: 21828272
[TBL] [Abstract][Full Text] [Related]
2. Interaction of c-Myb with p300 is required for the induction of acute myeloid leukemia (AML) by human AML oncogenes.
Pattabiraman DR; McGirr C; Shakhbazov K; Barbier V; Krishnan K; Mukhopadhyay P; Hawthorne P; Trezise A; Ding J; Grimmond SM; Papathanasiou P; Alexander WS; Perkins AC; Levesque JP; Winkler IG; Gonda TJ
Blood; 2014 Apr; 123(17):2682-90. PubMed ID: 24596419
[TBL] [Abstract][Full Text] [Related]
3. The mechanism of MYB transcriptional regulation by MLL-AF9 oncoprotein.
Cao L; Mitra P; Gonda TJ
Sci Rep; 2019 Dec; 9(1):20084. PubMed ID: 31882723
[TBL] [Abstract][Full Text] [Related]
4. miR-150 blocks MLL-AF9-associated leukemia through oncogene repression.
Bousquet M; Zhuang G; Meng C; Ying W; Cheruku PS; Shie AT; Wang S; Ge G; Wong P; Wang G; Safe S; Zhou B
Mol Cancer Res; 2013 Aug; 11(8):912-22. PubMed ID: 23604034
[TBL] [Abstract][Full Text] [Related]
5. NRASG12V oncogene facilitates self-renewal in a murine model of acute myelogenous leukemia.
Sachs Z; LaRue RS; Nguyen HT; Sachs K; Noble KE; Mohd Hassan NA; Diaz-Flores E; Rathe SK; Sarver AL; Bendall SC; Ha NA; Diers MD; Nolan GP; Shannon KM; Largaespada DA
Blood; 2014 Nov; 124(22):3274-83. PubMed ID: 25316678
[TBL] [Abstract][Full Text] [Related]
6. The AAA+ATPase RUVBL2 is essential for the oncogenic function of c-MYB in acute myeloid leukemia.
Armenteros-Monterroso E; Zhao L; Gasparoli L; Brooks T; Pearce K; Mansour MR; Martens JHA; de Boer J; Williams O
Leukemia; 2019 Dec; 33(12):2817-2829. PubMed ID: 31138842
[TBL] [Abstract][Full Text] [Related]
7. c-Myb binds MLL through menin in human leukemia cells and is an important driver of MLL-associated leukemogenesis.
Jin S; Zhao H; Yi Y; Nakata Y; Kalota A; Gewirtz AM
J Clin Invest; 2010 Feb; 120(2):593-606. PubMed ID: 20093773
[TBL] [Abstract][Full Text] [Related]
8. Neuromedin U: a Myb-regulated autocrine growth factor for human myeloid leukemias.
Shetzline SE; Rallapalli R; Dowd KJ; Zou S; Nakata Y; Swider CR; Kalota A; Choi JK; Gewirtz AM
Blood; 2004 Sep; 104(6):1833-40. PubMed ID: 15187020
[TBL] [Abstract][Full Text] [Related]
9. Targeting acute myeloid leukemia by drug-induced c-MYB degradation.
Walf-Vorderwülbecke V; Pearce K; Brooks T; Hubank M; van den Heuvel-Eibrink MM; Zwaan CM; Adams S; Edwards D; Bartram J; Samarasinghe S; Ancliff P; Khwaja A; Goulden N; Williams G; de Boer J; Williams O
Leukemia; 2018 Apr; 32(4):882-889. PubMed ID: 29089643
[TBL] [Abstract][Full Text] [Related]
10. Convergent organization of aberrant MYB complex controls oncogenic gene expression in acute myeloid leukemia.
Takao S; Forbes L; Uni M; Cheng S; Pineda JMB; Tarumoto Y; Cifani P; Minuesa G; Chen C; Kharas MG; Bradley RK; Vakoc CR; Koche RP; Kentsis A
Elife; 2021 Feb; 10():. PubMed ID: 33527899
[TBL] [Abstract][Full Text] [Related]
11. Overexpression of v-myb oncogene or c-myb proto-oncogene in insect cells: characterization of newly induced nucleolus-like structures accumulating Myb protein.
Stokrová J; Korb J; Pliss A; Raska I; Stulík J; Dvoráková M
Int J Mol Med; 2002 May; 9(5):547-54. PubMed ID: 11956664
[TBL] [Abstract][Full Text] [Related]
12. Targeting the Oncogenic Transcriptional Regulator MYB in Adenoid Cystic Carcinoma by Inhibition of IGF1R/AKT Signaling.
Andersson MK; Afshari MK; Andrén Y; Wick MJ; Stenman G
J Natl Cancer Inst; 2017 Sep; 109(9):. PubMed ID: 28954282
[TBL] [Abstract][Full Text] [Related]
13. Deregulated c-myb disrupts interleukin-6- or leukemia inhibitory factor-induced myeloid differentiation prior to c-myc: role in leukemogenesis.
Selvakumaran M; Liebermann DA; Hoffman-Liebermann B
Mol Cell Biol; 1992 Jun; 12(6):2493-500. PubMed ID: 1588953
[TBL] [Abstract][Full Text] [Related]
14. Peptidomimetic blockade of MYB in acute myeloid leukemia.
Ramaswamy K; Forbes L; Minuesa G; Gindin T; Brown F; Kharas MG; Krivtsov AV; Armstrong SA; Still E; de Stanchina E; Knoechel B; Koche R; Kentsis A
Nat Commun; 2018 Jan; 9(1):110. PubMed ID: 29317678
[TBL] [Abstract][Full Text] [Related]
15. Identification of a c-MYB-directed therapeutic for acute myeloid leukemia.
Clesham K; Walf-Vorderwülbecke V; Gasparoli L; Virely C; Cantilena S; Tsakaneli A; Inglott S; Adams S; Samarasinghe S; Bartram J; Williams G; de Boer J; Williams O
Leukemia; 2022 Jun; 36(6):1541-1549. PubMed ID: 35368048
[TBL] [Abstract][Full Text] [Related]
16. Hierarchical maintenance of MLL myeloid leukemia stem cells employs a transcriptional program shared with embryonic rather than adult stem cells.
Somervaille TC; Matheny CJ; Spencer GJ; Iwasaki M; Rinn JL; Witten DM; Chang HY; Shurtleff SA; Downing JR; Cleary ML
Cell Stem Cell; 2009 Feb; 4(2):129-40. PubMed ID: 19200802
[TBL] [Abstract][Full Text] [Related]
17. Integrated genome-wide chromatin occupancy and expression analyses identify key myeloid pro-differentiation transcription factors repressed by Myb.
Zhao L; Glazov EA; Pattabiraman DR; Al-Owaidi F; Zhang P; Brown MA; Leo PJ; Gonda TJ
Nucleic Acids Res; 2011 Jun; 39(11):4664-79. PubMed ID: 21317192
[TBL] [Abstract][Full Text] [Related]
18. Polycomb repressive complex 2 is required for MLL-AF9 leukemia.
Neff T; Sinha AU; Kluk MJ; Zhu N; Khattab MH; Stein L; Xie H; Orkin SH; Armstrong SA
Proc Natl Acad Sci U S A; 2012 Mar; 109(13):5028-33. PubMed ID: 22396593
[TBL] [Abstract][Full Text] [Related]
19. Learning from mouse models of MLL fusion gene-driven acute leukemia.
Schwaller J
Biochim Biophys Acta Gene Regul Mech; 2020 Aug; 1863(8):194550. PubMed ID: 32320749
[TBL] [Abstract][Full Text] [Related]
20. c-Myb is an essential downstream target for homeobox-mediated transformation of hematopoietic cells.
Hess JL; Bittner CB; Zeisig DT; Bach C; Fuchs U; Borkhardt A; Frampton J; Slany RK
Blood; 2006 Jul; 108(1):297-304. PubMed ID: 16507773
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
